Skip to main content
LucidCGTBy LucidQuest
Specialist strategic intelligence · By LucidQuest

Sharper strategic decisions in cell, gene & RNA therapies.

Navigate scientific complexity, competitive disruption and commercial uncertainty with evidence-led intelligence, strategic foresight and competitive simulations.

Discuss a strategic challenge ↗ Explore our expertise →
Competitive intelligenceStrategic wargamingInvestment insight
Strategic scenario radarIllustrative model
Strategy radar A radar centred on today. Its rings mark time out to the launch horizon. Several possible futures branch outward, shaped by trial readouts, competitor moves, payer responses and partnering. One path is highlighted as the chosen strategy. Trial readout Competitor move Partner deal Payer response Today Launch horizon Chosen strategy
Explore multiple futures.Test assumptions before you commit. ↗
Cell therapies · Gene therapies · RNA therapeuticsSpecialist perspective. Decision-grade insight.
Why LucidCGT

Science moves fast. Strategy must move faster.

Breakthrough science alone does not guarantee commercial success. Competitive dynamics, evidence expectations, patient access, financing and market readiness shape what happens next.

LucidCGT connects these signals to help leaders understand what is changing, challenge their assumptions and make clearer strategic choices.

EvidenceCompetitionMarket realities→Better decisions
Cell therapiesGene therapiesRNA therapeuticsEnabling technologiesAdvanced-therapy ecosystems
Our expertise

Built around the decisions you actually face.

Each engagement starts with a strategic question, brings together the evidence that matters and ends with practical options, not just another landscape report.

01 / INTELLIGENCE

Competitive intelligence

Understand the changing landscape.
The client questionWhat is changing in our competitive environment, and what does it mean for our strategy?

Primary research, expert insight and competitive analysis interpreted for strategic consequences.

Explore typical deliverables
  • Conference intelligence and expert interviews
  • Therapy and technology landscape mapping
  • Competitor profiles and strategic assessments
  • Clinical, regulatory and commercial catalyst tracking
  • Opportunity and threat assessment
Discuss an intelligence challenge ↗
02 / SIMULATION

Strategic wargaming

Test decisions before the market tests them.
The client questionHow might competitors, investors, payers or partners respond to our next move?

Facilitated competitive simulations and scenario workshops supported by LucidWargames, research and expert judgment.

Explore typical deliverables
  • Scenario design and competitive simulation
  • Competitor-response and launch stress tests
  • Portfolio and investment decision workshops
  • Strategic options and contingency actions
  • Early-warning indicators
Discuss a strategic stress test ↗
03 / COMMERCIAL

Commercial strategy

Translate innovation into viable market choices.
The client questionWhat will it take to turn scientific progress into a viable commercial opportunity?

Market, stakeholder and access analysis that connects the clinical story to competitive positioning and a realistic route to patients.

Explore typical deliverables
  • Market and stakeholder analysis
  • Competitor positioning
  • Treatment pathway and access-barrier assessment
  • Launch scenario planning
  • Commercial opportunity and risk evaluation
Discuss a commercial challenge ↗
04 / INVESTMENT

Investment & partnering

Evaluate opportunities with greater confidence.
The client questionIs this company, technology or asset strategically attractive?

Focused assessments of asset differentiation, commercial opportunity and competitive risks for investors and business development teams.

Explore typical deliverables
  • Commercial due diligence
  • Asset and platform differentiation analysis
  • Market attractiveness and risk mapping
  • Partnering opportunity assessment
  • Investment thesis stress testing
Discuss an investment question ↗

Our core focus is strategy, intelligence and decision support. Specialist GMP, CMC, clinical operations or regulatory execution requires appropriately qualified delivery partners.

Ways to work with us

Start focused. Go deeper when it matters.

Three practical engagement formats make it easier to move from an important question to a scoped piece of work.

01 / FOCUSED INTELLIGENCE

CGT Conference and Landscape Sprint

Priority congress coverage (e.g. ASGCT) plus a focused landscape assessment, distilled into decision-ready insights.

Illustrative: 2–3 weeks around a priority congressExplore a sprint ↗
02 / DECISION WORKSHOP

CGT Strategy Stress Test

A research-supported wargaming workshop that challenges assumptions, explores competitive responses and identifies practical contingencies.

Facilitated, workshop-led engagementExplore a stress test ↗
03 / ONGOING ADVISORY

CGT Intelligence Partner

A retained intelligence relationship combining monitoring, strategic briefings, expert interpretation and periodic scenario reviews.

Ongoing, tailored to your prioritiesExplore ongoing support ↗

Engagements are scoped and quoted individually. These are illustrative formats, not fixed-price packages.

A distinctive capability: Human-in-the-lead AI-powered workshops

Rehearse the market before you enter it.

Static research tells you what the landscape looks like. Strategic wargaming helps you explore how it might change when different players act, and how you could respond.

01

Frame the decision

Define the strategic choice, the stakeholders who matter and the assumptions that need testing.

02

Build the scenario

Ground potential moves and responses in research, evidence and expert interpretation.

03

Play it out

Explore alternative competitor and stakeholder responses using facilitated or AI-enabled simulations.

04

Decide & prepare

Translate the findings into strategic options, warning signals and contingency actions.

Strategy first. Technology in service of the decision.

We draw on LucidWargames ↗ alongside expert judgment. Scenarios are tools for exploring uncertainty, not predictions of guaranteed outcomes.

Launch sequencingCompetitor responseMarket-access scenariosPortfolio prioritizationInvestment stress testsPartnering strategyIndication selection
Who we help

For the people making advanced-therapy bets.

Focused strategic support for organizations navigating high-value scientific, competitive and commercial choices.

Innovators

Emerging biotech

Clarify differentiation, assess markets and strengthen pipeline, partnering and commercialization choices.

Industry leaders

Established biopharma

Anticipate competitive moves, stress-test launch assumptions and inform portfolio decisions.

Capital allocators

Investors & venture funds

Evaluate assets, modalities and commercial risks with focused, independent intelligence.

Ecosystem builders

Technology & service firms

Understand customer needs, market opportunities and competitive positioning across advanced therapies.

Our foundation

Specialist focus. Established intelligence capabilities.

LucidCGT builds on LucidQuest's biopharma research and strategic advisory experience, including its existing gene and cell therapy work.

We bring together research, competitive analysis and structured decision support to address the questions that matter most.

Primary intelligenceExpert interviewsCongress intelligenceCompetitive strategyInvestment insightDecision workshops
LucidQuest case study · Hemophilia Gene Therapy

Supporting branding and positioning in a changing treatment landscape.

How therapy landscape intelligence informed strategic positioning in a field being reshaped by innovation.

Read the LucidQuest case study ↗ LucidQuest case study · Ophthalmology Gene Therapy

Structuring a go/no-go decision in ophthalmology gene therapy.

An example of using a strategic workshop to support a consequential development decision.

Read the LucidQuest case study ↗ LucidQuest case study · Sickle cell disease Gene Therapy

Mapping cell and gene therapy competition for a top-10 biopharma.

Competitive landscape mapping and approval-likelihood estimates for rival assets, used to inform portfolio prioritization and new business development.

Read the LucidQuest case study ↗

These examples represent published LucidQuest experience, not separately claimed LucidCGT client engagements.

Our perspective

The questions shaping advanced therapies.

Our intelligence agenda focuses on the strategic consequences of scientific and market change, not just the headlines.

Competitive dynamics

Where will the next wave of differentiation emerge?

Exploring technology platforms, emerging clinical benchmarks and changing competitive expectations.

Commercial realities

What stands between scientific success and patient access?

Examining market readiness, treatment pathways and the ecosystem requirements of advanced therapies.

Strategic foresight

How should leaders prepare for multiple futures?

Using scenarios and competitive simulation to improve portfolio, investment and launch decisions.

Industry dialogue

Gene, Cell and RNA Therapy Strategy Network

Connect with professionals discussing emerging evidence, competitive developments and strategic questions across advanced therapies.

Explore the LinkedIn group ↗
The LucidQuest ecosystem

Connected capabilities. One strategic focus.

LucidCGT brings a dedicated advanced-therapy lens to complementary research, intelligence and simulation capabilities.

LucidQuest

Biopharma intelligence, primary research, competitive strategy and investment decision support.

Explore LucidQuest ↗

LucidWargames

AI-enabled competitive simulation and scenario-based strategy testing.

Explore LucidWargames ↗

LucidScope

Intelligence on how AI systems represent brands, therapies and competitive narratives.

Explore LucidScope ↗
Start a conversation

Your next decision deserves clarity.

Whether you're assessing a therapy, tracking competitors or stress-testing a strategic choice, let's explore the question behind the decision.

A focused first conversation

We'll discuss your question and, where there's a fit, suggest an approach.

Confidentiality matters

Please avoid sharing sensitive details in an initial message. NDA arrangements can be discussed before a deeper exchange.

Prefer email?

Reach us via info@lqventures.com.

Tell us what you're deciding.

This prepares an email draft in your mail application; nothing is sent or stored by the website. Send the draft to complete your enquiry. We handle enquiries under the LucidQuest privacy policy.